ReviewBlood reviews2020
Management of challenging myelofibrosis after JAK inhibitor failure and/or progression.
Robyn M Scherber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewBlood reviews2020
Robyn M Scherber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.